Insulin aspart, recombinant Subcutaneous and Lioresal Intrathecal
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Lioresal Intrathecal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: baclofen
Brand name: Gablofen, Lioresal, Lioresal Intrathecal, FIRST Baclofen, Ozobax
Synonyms: Lioresal (Intrathecal), Lioresal
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Liothyronine
- Insulin aspart, recombinant Subcutaneous-Liothyronine Injection
- Insulin aspart, recombinant Subcutaneous-Liothyronine Intravenous
- Insulin aspart, recombinant Subcutaneous-Liothyronine Sodium
- Insulin aspart, recombinant Subcutaneous-Liothyronine Tablets
- Insulin aspart, recombinant Subcutaneous-Liotrix
- Lioresal Intrathecal-Insulin degludec
- Lioresal Intrathecal-Insulin Degludec (U-100) Prefilled Pens
- Lioresal Intrathecal-Insulin Degludec (U-100) Vials
- Lioresal Intrathecal-Insulin Degludec (U-200) Prefilled Pens
- Lioresal Intrathecal-Insulin degludec and liraglutide
- Lioresal Intrathecal-Insulin degludec and liraglutide Subcutaneous